Neurologic Drugs News

News

Momenta Pharmaceuticals' CEO Discusses Q4 2011 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com | Feb 9, 2012
< p > Momenta Pharmaceuticals Inc. ( < a href='http://seekingalpha.com/symbol/mnta' title='Momenta Pharmaceuticals, Inc.' > MNTA < /a > ) < /p > < p > Q4 2011 Earnings Call < /p > < p > February 9, 2012 10:00 am ET < /p > < p > < strong > Executives < /strong > < /p > < p > Beverly Holley -

Impax Pharmaceuticals Gains Rights for US Sales of
www.biospace.com | Feb 1, 2012
HAYWARD, Calif.---- Impax Pharmaceuticals, the branded products business unit of Impax Laboratories, Inc. , announced today that it has licensed from

Pain Therapeutics - Drugs, Markets and Companies | SYS-CON MEDIA
www.sys-con.com | Dec 29, 2011
SYS-CON Media, NJ, The world's leading i-technology media company on breaking technology news.

Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2018 | PRLog
www.prlog.org | Dec 9, 2011
Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The Epilepsy Therapeutics Market is forecast to Register Slow Growth Through 2018 - PR11745363

New epilepsy drugs overused in children | 6minutes
www.6minutes.com.au | Nov 4, 2011
There has been a sharp and unjustified rise in the use of newer and more expensive anticonvulsants in children, an Australian study has shown.

The Consume Justice Foundation Alerts the Public of Third-Quarter Sales for Topamax Despite Reports
www.prweb.com | Oct 28, 2011
The Consumer Justice Foundation, a for-profit corporation that is staffed by a team of professional consumer advocates whose mission is to alert the public of potential dangers associated with the use of prescription medications and whose URL can be found at http://www.topamaxbirthinjury.com,

Man held over Nurofen contamination - Scotsman.com News
news.scotsman.com | Sep 25, 2011
Man held over Nurofen contamination - DETECTIVES investigating how packs of Nurofen Plus were found to contain anti-psychotic and anti-epileptic drugs were yesterday questioning a man in custody.

Pfizer announces phase 3 study results of patients with Fibromyalgia in Japan | Pharma Asia
www.pharmaasia.com | Jul 7, 2011
Pfizer Japan announced the top-line results for Lyrica (pregabalin) Study A0081208 – Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate Efficacy and Safety of Pregabalin (CI-1008) in the Treatment of Fibromyalgia. According to the company, the results demonstrated a

Abbott Reports Interim Results from Phase III Open-Label Study of Investigational Treatment for
www.abbott.com | Jun 9, 2011
Abbott Reports Interim Results from Phase III Open-Label Study of Investigational Treatment for Advanced Parkinson's Disease

Medical News: Survival in MS-based PML Improves, But Disability Still High - in Neurology, General
www.medpagetoday.com | May 22, 2011
Survival has improved dramatically for patients with multiple sclerosis who develop progressive multifocal leukoencephalopathy (PML) during treatment with natalizumab (Tysabri), a study found.